Table 2.
Correlation between the miR-206 expression and clinicopathologic parameters of patients with epithelium ovarian cancer
| Clinicopathologic parameters | N | miR-206 expression | P | |
|---|---|---|---|---|
| Low | High | |||
| Age in years | 0.253 | |||
| < 50 | 18 | 10 | 8 | |
| ≥ 50 | 21 | 10 | 11 | |
| Subtypes | ||||
| LGSC | 4 | 2 | 2 | 0.229 |
| HGSC | 35 | 18 | 17 | |
| FIGO stage | 0.183 | |||
| I | 2 | 0 | 2 | |
| II | 3 | 2 | 1 | |
| III | 32 | 18 | 14 | |
| IV | 2 | 0 | 2 | |
| LN metastasis | 0.268 | |||
| Absent | 13 | 7 | 6 | |
| Present | 26 | 14 | 12 | |
| Chemotherapy | ||||
| CR | 20 | 16 | 4 | 0.001 |
| IR | 19 | 4 | 15 | |
N, number; FIGO stage, International Federation of Gynecology and Obstetrics stage; P, P-value; LGSC, low grade serous carcinoma; HGSC, high grade serous carcinoma; CR, complete response; IR, incomplete response
The Ps set in italic considered statistically significant at < 0.05